92O Analysis of study drug-related interstitial lung disease (ILD) in patients (pts) with HER2+ metastatic breast cancer (mBC) treated with trastuzumab deruxtecan (T-DXd)
| Autor: | Powell, C.A., Modi, S., Iwata, H., Takahashi, S., Nie, K., Qin, A., Singh, J., Taitt, C., Verma, S., Camidge, D.R. |
|---|---|
| Zdroj: | In Annals of Oncology May 2021 32 Supplement 2:S61-S62 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|